{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:31:08Z","timestamp":1773268268855,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.4158\/ep161545.or","type":"journal-article","created":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T16:30:04Z","timestamp":1479313804000},"page":"170-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["In Patients With Subclinical Hypothyroidism While in Therapy With Tablet L-T4, the Liquid L-T4 Formulation is More Effective in Restoring Euthyroidism"],"prefix":"10.1016","volume":"23","author":[{"given":"Poupak","family":"Fallahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia Martina","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP161545.OR_bb0010","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1089\/thy.2012.0205","article-title":"Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association","volume":"22","author":"Garber","year":"2012","journal-title":"Thyroid"},{"key":"10.4158\/EP161545.OR_bb0015","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","article-title":"Autoimmune thyroid disorders","volume":"14","author":"Antonelli","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.4158\/EP161545.OR_bb0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/thy.1995.5.249","article-title":"Delayed intestinal absorption of levothyroxine","volume":"5","author":"Benvenga","year":"1995","journal-title":"Thyroid"},{"key":"10.4158\/EP161545.OR_bb0025","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa043903","article-title":"Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis","volume":"354","author":"Centanni","year":"2006","journal-title":"N Engl J Med"},{"key":"10.4158\/EP161545.OR_bb0030","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1210\/jc.2007-1544","article-title":"L-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies","volume":"93","author":"Checchi","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161545.OR_bb0035","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/thy.2007.0222","article-title":"Altered intestinal absorption of L-thyroxine caused by coffee","volume":"18","author":"Benvenga","year":"2008","journal-title":"Thyroid"},{"key":"10.4158\/EP161545.OR_bb0040","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.beem.2009.06.006","article-title":"Conditions and drugs interfering with thyroxine absorption","volume":"23","author":"Liwanpo","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.4158\/EP161545.OR_bb0045","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1210\/jc.2014-2684","article-title":"Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors","volume":"99","author":"Vita","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161545.OR_bb0050","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1517\/17425247.2014.918101","article-title":"The administration of L-thyroxine as soft gel capsule or liquid solution","volume":"11","author":"Vita","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"key":"10.4158\/EP161545.OR_bb0055","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jpeds.2012.11.070","article-title":"Comparison between liquid and tablet formulations of levothyroxine in the initial treatment of congenital hypothyroidism","volume":"162","author":"Cassio","year":"2013","journal-title":"J Pediatr"},{"key":"10.4158\/EP161545.OR_bb0060","doi-asserted-by":"crossref","first-page":"657","DOI":"10.4158\/EP13418.OR","article-title":"Comparison of TSH Levels with Liquid Formulation Versus Tablet Formulations of Levothyroxine in the Treatment of Adult Hypothyroidism","volume":"20","author":"Brancato","year":"2014","journal-title":"Endocr Pract"},{"key":"10.4158\/EP161545.OR_bb0065","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s12020-015-0836-y","article-title":"Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study","volume":"52","author":"Fallahi","year":"2016","journal-title":"Endocrine"},{"key":"10.4158\/EP161545.OR_bb0070","doi-asserted-by":"crossref","first-page":"E1454","DOI":"10.1210\/jc.2014-1217","article-title":"Systematic appraisal of lactose intolerance as cause of increased need for oral thyroxine","volume":"99","author":"Cellini","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161545.OR_bb0075","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s12020-015-0788-2","article-title":"Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulation","volume":"52","author":"Morelli","year":"2016","journal-title":"Endocrine"},{"key":"10.4158\/EP161545.OR_bb0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/thy.2015.0422","article-title":"A Double-Blind Placebo-Controlled Trial of Liquid Thyroxine Ingested at Breakfast: Results of the TICO Study","volume":"26","author":"Cappelli","year":"2016","journal-title":"Thyroid"},{"key":"10.4158\/EP161545.OR_bb0085","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12876-016-0439-y","article-title":"Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series","volume":"16","author":"Fallahi","year":"2016","journal-title":"BMC Gastroenterol"},{"key":"10.4158\/EP161545.OR_bb0090","article-title":"TSH normalization in bariatric surgery patients after the switch from L-thyroxine in tablet to an oral liquid formulation","author":"Fallahi","year":"2016","journal-title":"Obes Surg"},{"key":"10.4158\/EP161545.OR_bb0095","doi-asserted-by":"crossref","first-page":"901","DOI":"10.4158\/EP13378.OR","article-title":"Levothyroxine liquid solution versus tablet for replacement treatment in hypothyroid patients","volume":"20","author":"Negro","year":"2014","journal-title":"Endocr Pract"},{"key":"10.4158\/EP161545.OR_bb0100","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2165\/00003088-200443140-00006","article-title":"Assessment of levothyroxine sodium bioavailability: recommendations for an improved methodology based on the pooled analysis of eight identically designed trials with 396 drug exposures","volume":"43","author":"Walter-Sack","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.4158\/EP161545.OR_bb0105","first-page":"680","article-title":"Bioequivalence study of levothyroxine tablets compared to reference tablets and an oral solution","volume":"54","author":"Koytchev","year":"2004","journal-title":"Arzneimittelforschung"},{"key":"10.4158\/EP161545.OR_bb0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF03191122","article-title":"A bioequivalence study of levothyroxine tablets versus an oral levothyroxine solution in healthy volunteers","volume":"31","author":"Yannovits","year":"2006","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.4158\/EP161545.OR_bb0115","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1055\/s-0032-1329951","article-title":"Pharmacokinetics and potential advantages of a new oral solution of levothyroxine vs. other available dosage forms","volume":"62","author":"Yue","year":"2012","journal-title":"Arzneimittelforschung"},{"key":"10.4158\/EP161545.OR_bb0120","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00003088-200241090-00003","article-title":"Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications","volume":"41","author":"Zhang","year":"2002","journal-title":"Clin Pharmacokinet"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20355555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20355555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:02:56Z","timestamp":1761516176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20355555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1530891X20355555"],"URL":"https:\/\/doi.org\/10.4158\/ep161545.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Patients With Subclinical Hypothyroidism While in Therapy With Tablet L-T4, the Liquid L-T4 Formulation is More Effective in Restoring Euthyroidism","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP161545.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}